These results suggest that nimbolide induced G2/M phase cell cycle arrest in bladder cancer cells via Chk2-Cdc25C-Cdc2/cyclin B1-Wee1 pathway and Chk2-p21WAF1-Cdc2/cyclin B1-Wee1 pathway. Here, CDC25C is linked to urinary bladder cancer.